Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 04 02 2022
accepted: 23 05 2022
entrez: 14 7 2022
pubmed: 15 7 2022
medline: 16 7 2022
Statut: epublish

Résumé

Achieving fast immunosuppression blood exposure after kidney transplantation is key to abrogating both preformed and

Identifiants

pubmed: 35833145
doi: 10.3389/fimmu.2022.869554
pmc: PMC9272702
doi:

Substances chimiques

CYP3A protein, human EC 1.14.14.1
Cytochrome P-450 CYP3A EC 1.14.14.1
Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

869554

Informations de copyright

Copyright © 2022 Crespo, Vidal-Alabró, Jouve, Fontova, Stein, Mocka, Meneghini, Sefrin, Hruba, Gomà, Torija, Donadeu, Favà, Cruzado, Melilli, Moreso, Viklicky, Bemelman, Reinke, Grinyó, Lloberas and Bestard.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer L.R has declared a shared affiliation with the author T.J to the handling editor at the time of review.

Références

N Engl J Med. 2007 Dec 20;357(25):2562-75
pubmed: 18094377
Am J Transplant. 2005 Mar;5(3):465-74
pubmed: 15707400
Expert Rev Clin Immunol. 2010 Jan;6(1):155-69
pubmed: 20383898
Am J Transplant. 2003 May;3(5):525-33
pubmed: 12752308
J Immunol. 2007 Oct 15;179(8):5584-91
pubmed: 17911646
Transpl Int. 2011 May;24(5):451-60
pubmed: 21294788
J Am Soc Nephrol. 2018 Jul;29(7):1979-1991
pubmed: 29752413
N Engl J Med. 1969 Apr 3;280(14):735-9
pubmed: 4886455
Pharmacogenomics. 2011 Oct;12(10):1383-96
pubmed: 21902502
Am J Transplant. 2013 Mar;13(3):589-99
pubmed: 23331999
Am J Transplant. 2017 Jan;17(1):28-41
pubmed: 27862883
Nat Rev Nephrol. 2014 Dec;10(12):725-31
pubmed: 25247332
Am J Transplant. 2007 May;7(5):1055-61
pubmed: 17286617
Transplant Direct. 2019 Apr 25;5(5):e451
pubmed: 31165086
Adv Exp Med Biol. 2007;601:247-56
pubmed: 17713012
Transplantation. 2014 May 27;97(10):986-91
pubmed: 24784360
J Immunol. 2006 Apr 15;176(8):4632-9
pubmed: 16585554
Clin Pharmacol Ther. 2010 Jun;87(6):721-6
pubmed: 20393454
Clin Chem. 2011 Nov;57(11):1574-83
pubmed: 21903774
Transpl Int. 2013 Oct;26(10):982-9
pubmed: 23879408
Transplantation. 2011 Feb 15;91(3):300-8
pubmed: 21206424
Transplantation. 1996 Oct 15;62(7):920-6
pubmed: 8878385
Pharmacogenet Genomics. 2017 Sep;27(9):313-322
pubmed: 28704257
Transplantation. 2004 Dec 15;78(11):1640-6
pubmed: 15591953
Am J Transplant. 2013 Jul;13(7):1880-90
pubmed: 23763435
Pharmacogenomics. 2016 Jun;17(9):1019-27
pubmed: 27266721
PLoS One. 2015 Feb 17;10(2):e0117618
pubmed: 25689405
Clin Pharmacokinet. 2004;43(10):623-53
pubmed: 15244495
Transplantation. 2003 Oct 27;76(8):1233-5
pubmed: 14578760
Kidney Int. 2013 Dec;84(6):1226-36
pubmed: 23783240
Am J Transplant. 2015 Mar;15(3):800-5
pubmed: 25588704
Am J Transplant. 2014 Feb;14(2):272-83
pubmed: 24472190
Am J Transplant. 2013 Jul;13(7):1871-9
pubmed: 23710568

Auteurs

Elena Crespo (E)

Nephrology and Transplant Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.

Anna Vidal-Alabró (A)

Experimental Nephrology and Transplantation Laboratory, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.

Thomas Jouve (T)

Nephrology and Transplant Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.
Faculty of Health, Université Grenoble Alpes, Grenoble, France.
Institute for Advanced Biosciences, INSERM 1209, CNRS 5309, Grenoble, France.

Pere Fontova (P)

Experimental Nephrology and Transplantation Laboratory, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.

Maik Stein (M)

Berlin Center for Advanced Therapies (BeCAT), Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Sonila Mocka (S)

Experimental Nephrology and Transplantation Laboratory, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.

Maria Meneghini (M)

Nephrology and Transplant Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.
Kidney Transplant Unit and Nephrology Department, Vall d'Hebron Hospital, Barcelona, Spain.

Anett Sefrin (A)

Berlin Center for Advanced Therapies (BeCAT), Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Petra Hruba (P)

Department of Nephrology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia.

Montserrat Gomà (M)

Pathology Department, Bellvitge University Hospital, Barcelona, Spain.

Alba Torija (A)

Nephrology and Transplant Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.

Laura Donadeu (L)

Nephrology and Transplant Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.

Alex Favà (A)

Kidney Transplant Unit, Nephrology Department, Bellvitge University Hospital, Barcelona, Spain.

Josep M Cruzado (JM)

Kidney Transplant Unit, Nephrology Department, Bellvitge University Hospital, Barcelona, Spain.

Edoardo Melilli (E)

Kidney Transplant Unit, Nephrology Department, Bellvitge University Hospital, Barcelona, Spain.

Francesc Moreso (F)

Kidney Transplant Unit and Nephrology Department, Vall d'Hebron Hospital, Barcelona, Spain.

Ondrej Viklicky (O)

Department of Nephrology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia.

Frederike Bemelman (F)

Renal Transplant Unit, Department of Internal Medicine, Amsterdam University Medical Centers, Academic Medical Center-University of Amsterdam, Amsterdam, Netherlands.

Petra Reinke (P)

Berlin Center for Advanced Therapies (BeCAT), Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Josep Grinyó (J)

Department of Clinical Sciences, Barcelona University, Barcelona, Spain.

Nuria Lloberas (N)

Experimental Nephrology and Transplantation Laboratory, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.

Oriol Bestard (O)

Nephrology and Transplant Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.
Kidney Transplant Unit and Nephrology Department, Vall d'Hebron Hospital, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH